NR4A1 and breast cancer: Breast cancer has undergone several classifications over time, but the most used and widely accepted classification system of breast cancer involves the assessment of the expression of estrogen (ER), progesterone (PR), and human epidermal growth factor 2 (HER2) hormone receptors via immunohistochemical analysis.